Guntur neurosurgeon says MRI can change trigeminal neuralgia treatment

On World Trigeminal Neuralgia Awareness Day, Dr. Mohana Rao Patibandla of Dr. Rao’s Hospital in Guntur is urging clinicians to look beyond pain relief and assess whether neurovascular compression is driving the pain. The hospital says its experience with more than 440 patients supports using microvascular decompression for selected patients with classical trigeminal neuralgia.

Why it matters: - Trigeminal neuralgia can send patients through repeated medications and procedures without addressing the underlying cause. - When classical trigeminal neuralgia is paired with convincing neurovascular compression on MRI, treatment can shift from symptom control to correcting the nerve-vessel conflict. - That distinction affects long-term pain relief, facial sensation and whether a patient should consider surgery.

What happened: - Dr. Mohana Rao Patibandla, chief neurosurgeon and founder of Dr. Rao’s Hospital – International Institute of Neurosciences (IIN) in Guntur, used World Trigeminal Neuralgia Awareness Day to argue that clinicians should ask whether the cause of pain can be treated. - Dr. Rao’s IIN reports experience treating more than 440 patients with trigeminal neuralgia. - The institution reports about 213 microvascular decompression procedures, including about 114 endoscopic procedures. - The reported experience also includes stereotactic radiosurgery, balloon compression and radiofrequency procedures.

The details: - Trigeminal neuralgia causes severe facial pain that patients often describe as electric shocks, stabbing or lightning-like attacks. - Talking, chewing, brushing teeth, touching the face or even a light breeze can trigger episodes. - Some patients first seek dental treatment because the pain can occur in the jaw, cheek or teeth. - When dental disease does not explain the attacks, a neurological cause should be considered. - The American Family Physician rapid evidence review recommends brain MRI for suspected trigeminal neuralgia to exclude other causes and assess treatment and surgical candidacy. - The European Academy of Neurology guideline also recommends MRI and distinguishes classical trigeminal neuralgia from idiopathic and secondary forms. - The guideline cautions that neurovascular contact on MRI alone does not establish the diagnosis. - Microvascular decompression separates the offending blood vessel from the trigeminal nerve, usually with a protective material placed between them. - The procedure does not intentionally destroy the trigeminal nerve. - Procedures such as radiofrequency ablation, balloon compression and stereotactic radiosurgery work differently because they intentionally interrupt trigeminal nerve transmission or use other nondecompressive approaches. - The European Academy of Neurology guideline recommends microvascular decompression as first-line surgery for classical trigeminal neuralgia when surgery is indicated. - Comparative evidence cited by Dr. Rao’s IIN says MVD has higher short- and long-term pain-freedom rates than stereotactic radiosurgery, with less facial numbness and dysesthesia but more postoperative complications. - A prospective comparison cited in the release reported pain-free rates after MVD of 83% at five years versus 47% after stereotactic radiosurgery. - The same comparison reported a longer median time to pain recurrence after MVD. - More recent comparative evidence cited in the release found longer pain-free intervals and lower recurrence with MVD than with radiofrequency ablation and stereotactic radiosurgery, while noting higher procedural risk with MVD. - Dr. Rao said MRI should never be interpreted in isolation and must be matched with symptoms and neurological examination. - The hospital says its procedural counts are institutional experience, not unique patient counts, and one patient may undergo more than one procedure. - The reported breakdown includes 76 stereotactic radiosurgery procedures, 35 balloon compression/rhizotomy procedures and 120 radiofrequency ablation procedures.

Between the lines: - The core argument is not that every trigeminal neuralgia patient needs surgery. - The message is that repeated procedures can be a sign to reassess diagnosis, imaging and treatment strategy instead of repeating the same intervention automatically. - The release positions MVD as the benchmark surgical option for medically fit patients with classical trigeminal neuralgia and convincing neurovascular compression. - That benchmark approach favors durable pain relief and preservation of facial sensation, but it also requires accepting the risks of intracranial surgery. - Age, medical fitness, MRI findings, prior procedures and patient preference all affect whether MVD makes sense. - Less invasive options may be better for older patients, patients with significant comorbidities or patients without convincing neurovascular compression. - The treatment options listed include medical therapy, nerve blocks, radiofrequency ablation, balloon compression/rhizotomy, stereotactic radiosurgery and endoscopic-assisted MVD in selected cases. - Dr. Rao said patients should ask whether their symptoms fit classical trigeminal neuralgia, whether MRI shows convincing neurovascular compression and what durable benefit and risks each procedure offers.

What's next: - Dr. Rao’s IIN says patients whose pain returns should prompt a fresh review of the diagnosis, MRI and treatment plan. - The hospital wants more patients and clinicians to frame the question as whether the underlying cause can be treated, not only which procedure provides the fastest pain relief. - For appropriately selected patients, the release says MVD should remain a serious discussion because it can offer durable pain relief without deliberately injuring the trigeminal nerve.

The bottom line: - In classical trigeminal neuralgia, the right MRI can change the decision from repeated pain control to treating the nerve compression itself.